CISS

C3is Inc.

There isn't enough reported data to score CISS yet.

RKLB

Rocket Lab USA, Inc.

56
Fundamentals66/ 100
Valuation50/ 100
Upside potential66/ 100
Risk potential46/ 100

RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.

CISS Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Unavailable

CISS's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.

RKLB Fundamentals

MetricStatus
Strong
Under pressure
Weak
Unavailable

RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.

CISS PE Valuation

CISS has no meaningful PE right now: it lost money over the past year.

RKLB PE Valuation

RKLB has no meaningful PE right now: it lost money over the past year.

CISS Forward outlook

There aren't enough analyst estimates for CISS to show an outlook.

RKLB Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Limited
Low

Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

CISS Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.75 on Nov 12.

There is not enough scenario data to compare CISS and RKLB's risk to reward.

RKLB Risk to reward

ScenarioChangePrice
Upside+88%$120.71
Downside-46%$34.64

Calculated from the latest close: $64.07 on Nov 12.

There is not enough scenario data to compare CISS and RKLB's risk to reward.

CISS Earnings Per Share

Q4 2024: $-2,527,560.00Q2 2025: $-593,040.00Q4 2025: $111,440.00
Q4 2024: $-2,527,560.00Q2 2025: $-593,040.00Q4 2025: $111,440.00
QuarterTTM EPSYoY
Q4 2025$111,440.00+$2,639,000.00

CISS and RKLB do not have enough comparable growth data to identify a winner.

RKLB Earnings Per Share

Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
Q4 2023: $-0.38Q1 2024: $-0.37Q2 2024: $-0.35Q3 2024: $-0.37Q4 2024: $-0.38Q1 2025: $-0.41Q2 2025: $-0.46Q3 2025: $-0.39Q4 2025: $-0.37Q1 2026: $-0.32Q2 2026: $-0.27Q3 2026: $-0.36
QuarterTTM EPSYoY
Q3 2026-$0.36+$0.03
Q2 2026-$0.27+$0.19
Q1 2026-$0.32+$0.09
Q4 2025-$0.37+$0.01
Q3 2025-$0.39-$0.02
Q2 2025-$0.46-$0.11
Q1 2025-$0.41-$0.04
Q4 2024-$0.38$0.00

RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.

CISS Quarterly Revenue

Q4 2023: $29MQ2 2024: $24MQ4 2024: $19MQ2 2025: $19MQ4 2025: $15M
Q4 2023: $29MQ2 2024: $24MQ4 2024: $19MQ2 2025: $19MQ4 2025: $15M
QuarterRevenueYoY
Q4 2025$15.3M-18%
Q2 2025$19.4M-18%
Q4 2024$18.7M-35%

RKLB has the edge over CISS in the latest year-over-year revenue comparison.

RKLB Quarterly Revenue

Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
Q4 2023: $60MQ1 2024: $93MQ2 2024: $106MQ3 2024: $105MQ4 2024: $132MQ1 2025: $123MQ2 2025: $144MQ3 2025: $155MQ4 2025: $180MQ1 2026: $200MQ2 2026: $234MQ3 2026: $268M
QuarterRevenueYoY
Q3 2026$267.8M+73%
Q2 2026$234.1M+62%
Q1 2026$200.3M+63%
Q4 2025$179.7M+36%
Q3 2025$155.1M+48%
Q2 2025$144.5M+36%
Q1 2025$122.6M+32%
Q4 2024$132.4M+121%

RKLB has the edge over CISS in the latest year-over-year revenue comparison.

CISS Free Cash Flow

Q4 2023: $1MQ2 2024: $20MQ4 2024: $4MQ2 2025: $3MQ4 2025: $1M
Q4 2023: $1MQ2 2024: $20MQ4 2024: $4MQ2 2025: $3MQ4 2025: $1M
QuarterFree cash flowYoY
Q4 2025$1.1M-71%
Q2 2025$2.8M-86%
Q4 2024$3.6M+168%

CISS and RKLB do not have enough comparable growth data to identify a winner.

RKLB Free Cash Flow

Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
Q4 2023: −$53MQ1 2024: −$22MQ2 2024: −$28MQ3 2024: −$42MQ4 2024: −$24MQ1 2025: −$83MQ2 2025: −$55MQ3 2025: −$69MQ4 2025: −$114MQ1 2026: −$77MQ2 2026: −$110MQ3 2026: −$24M
QuarterFree cash flowYoY
Q3 2026-$23.9M+$45.5M
Q2 2026-$110.1M-$54.8M
Q1 2026-$77.4M+$5.5M
Q4 2025-$114.2M-$90.2M
Q3 2025-$69.4M-$27.5M
Q2 2025-$55.3M-$26.9M
Q1 2025-$82.9M-$61.1M
Q4 2024-$23.9M+$28.7M

RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.

CISS Total Shares

Q2 2024: 6Q2 2025: 64
Q2 2024: 6Q2 2025: 64
PeriodChange %Net change
Quarterly+967%+58 shares

RKLB Total Shares

Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
Q4 2023: 482MQ1 2024: 490MQ2 2024: 494MQ3 2024: 498MQ4 2024: 496MQ1 2025: 506MQ2 2025: 515MQ3 2025: 529MQ4 2025: 531MQ1 2026: 605MQ2 2026: 630MQ3 2026: 652M
PeriodChange %Net change
Quarterly+3.6%+22.6M shares
1 year+23%+124M shares
3 years+35%+168M shares
5 years+46%+204M shares

RKLB has 652M diluted shares, up 23% from a year ago.

CISS Net Leverage

RKLB Net Leverage

RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

CISS Weekly Momentum

MetricValueStatus
RSI11.6Oversold
Stochastic1.5Oversold

CISS's weekly RSI is 12 (oversold) and its Stochastic is 2 (oversold).

RKLB Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic27.6Neutral

RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).

CISS PE vs Industrials Sector

CISS has no meaningful PE right now: it lost money over the past year.

RKLB PE vs Industrials Sector

RKLB has no meaningful PE right now: it lost money over the past year.

CISS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.1544% below
20 week MA$64.097% below
50 week MA$2,341.9100% below
100 week MA$58,887.4100% below

RKLB has stronger trend alignment. CISS is above 0 of 4 weekly averages versus RKLB above 3 of 5.

RKLB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$61.44.3% above
20 week MA$68.15.9% below
50 week MA$77.617% below
100 week MA$56.513% above
200 week MA$31.4104% above

RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.

CISS Yearly ROI

YearStart priceEnd priceROI
2023$238,140,000.0$23,175,600.0-90%
2024$23,175,600.0$320,598.6-99%
2025$320,598.6$5,908.0-98%
2026 YTD$5,908.0$1.75-100%

CISS has finished every year since 2023 lower, and it's down 100% so far in 2026.

RKLB Yearly ROI

YearStart priceEnd priceROI
2020$9.82$10.3+4.9%
2021$10.3$12.0+17%
2022$12.0$3.77-69%
2023$3.77$5.53+47%
2024$5.53$27.2+392%
2025$27.2$70.7+160%
2026 YTD$70.7$64.1-9.3%

RKLB has the edge over CISS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key